Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

A group of blood thinners used to reduce the risk of deep vein blood clots in patients has updated their products’ safety labeling and revised the boxed warning to include a risk of epidural or spinal hemotomas in some patients, according to an announcement by the Food and Drug Administration (FDA). The FDA places boxed warnings, also known as black box warnings, on drugs that, based on medical studies, carry a significant risk of serious adverse side effects or death.

Read the rest of this entry »

Enoxaparin, a low-molecular weight heparin, is getting praise from the Journal of Human Fertility for its safety and effectiveness for the prophylactic treatment of women with thrombophilia and recurrent in vitro fertilization-embryo transfer (IVF-ET) failures, according to IVG News.Direct!

Read the rest of this entry »

Cancer Consultants, an oncology resource center, is reporting that prophylactic use of nadroparin, a low-molecular-weight heparin, significantly reduces the incidence of thromboembolic events in patients who have cancer and are undergoing chemotherapy. This finding was presented this week by Italian researchers with the PROTECHT Study, at the annual meeting of the American Society of Hemotology.

Read the rest of this entry »